Ascorbic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00126 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 39 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | non-syndromic esophageal malformation | KG + DL |
| 2 | esophageal disease | KG + DL |
| 3 | congenital prothrombin deficiency | KG + DL |
| 4 | injury | KG + DL |
| 5 | biotin metabolic disease | KG + DL |
| 6 | perinatal disease | KG + DL |
| 7 | segmental odontomaxillary dysplasia | KG + DL |
| 8 | florid cemento-osseous dysplasia | KG + DL |
| 9 | disease by subcellular system affected | KG + DL |
| 10 | vitamin deficiency disorder | KG + DL |
| 11 | radiation or chemically induced disorder | KG + DL |
| 12 | cell proliferation disorder | KG + DL |
| 13 | iatrogenic disease | KG + DL |
| 14 | regional odontodysplasia | KG + DL |
| 15 | esophageal ulcer | KG + DL |
| 16 | esotropia | KG + DL |
| 17 | glycerol metabolism disease | KG + DL |
| 18 | hemorrhagic disease of newborn | KG + DL |
| 19 | anemia of prematurity | KG + DL |
| 20 | ochronosis disorder | KG + DL |
| 21 | folic acid deficiency anemia | KG + DL |
| 22 | Keshan disease | KG + DL |
| 23 | steatitis | KG + DL |
| 24 | choline deficiency disease | KG + DL |
| 25 | potassium deficiency | KG + DL |
| 26 | swayback | KG + DL |
| 27 | bone fracture | KG + DL |
| 28 | gonococcal urethritis | KG + DL |
| 29 | Ureaplasma urethritis | KG + DL |
| 30 | burn | KG + DL |
| 31 | ariboflavinosis | KG + DL |
| 32 | protein-energy malnutrition | KG + DL |
| 33 | urinary tract infection (disease) | KG + DL |
| 34 | magnesium deficiency | KG + DL |
| 35 | inborn error of biotin metabolism | KG + DL |
| 36 | spinal injury | KG + DL |
| 37 | uterine inflammatory disease | KG + DL |
| 38 | nasal cavity disease | KG + DL |
| 39 | ankle injury | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.